TY  - GEN
AU  - Wang,Yao
AU  - Zhang,Wen-ying
AU  - Han,Qing-wang
AU  - Liu,Yang
AU  - Dai,Han-ren
AU  - Guo,Ye-lei
AU  - Bo,Jian
AU  - Fan,Hui
AU  - Zhang,Yan
AU  - Zhang,Ya-jing
AU  - Chen,Mei-xia
AU  - Feng,Kai-chao
AU  - Wang,Quan-shun
AU  - Fu,Xiao-bing
AU  - Han,Wei-dong
TI  - Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells
SN  - 1521-7035
PY  - 2015///0219
KW  - Aged
KW  - Aged, 80 and over
KW  - Antigens, CD20
KW  - genetics
KW  - Cell Line
KW  - Combined Modality Therapy
KW  - Cytotoxicity, Immunologic
KW  - Female
KW  - Gene Dosage
KW  - Gene Order
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - adverse effects
KW  - Lymphocyte Count
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - diagnosis
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Positron-Emission Tomography
KW  - Protein Binding
KW  - Receptors, Antigen, T-Cell
KW  - Recombinant Fusion Proteins
KW  - T-Cell Antigen Receptor Specificity
KW  - immunology
KW  - T-Lymphocytes
KW  - Tomography, X-Ray Computed
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor Receptor Superfamily, Member 9
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clim.2014.10.002
ER  -